3.400USD-0.08%Mkt Cap: 519.47M USDP/E: —Last update: 2026-06-01
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap519.47M USD
Enterprise Value232.40M USD
Revenue (TTM)38.69M USD
Gross Profit-42.27M USD
Net Income (TTM)-160.06M USD
Revenue/Share0.4190 USD
Last Price3.400 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees87
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS28106W1036
Valuation
P/E (Trailing)—
P/E (Forward)-3.69
PEG—
EV/EBITDA-2.73
EV/Revenue6.01
P/S13.72
P/B76.89
EPS (TTM)-1.14
EPS (Forward)-0.94
52W Range
1.66060% of range4.537
52W High4.537 USD
52W Low1.660 USD
Profitability
Gross Margin-109.24%
Oper. Margin-883.19%
EBITDA Margin-220.16%
Profit Margin-395.01%
ROE-586.56%
ROA-85.81%
Growth
Revenue Growth-39.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-165.24M USD
CapEx (TTM)607.00K USD
FCF Margin-190.77%
FCF Yield-14.21%
Net Debt-106.35M USD
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.66
Current Ratio3.22
Quick Ratio3.17
Book Value/Sh0.0450 USD
Cash/Share1.263 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)5.778 USD
Target Range1.000 USD – 15.00 USD
# Analysts9
Ownership
Shares Out.153.46M
Float97.64M
Insiders0.18%
Institutions32.02%
Short Interest
Short Ratio7.4d
Short % Float9.79%
Short % Out.9.77%
Shares Short9.56M
Short (prev mo.)10.92M
Technical
SMA 502.864 (+18.7%)
SMA 2002.663 (+27.7%)
Beta2.14
S&P 52W Chg27.94%
Avg Vol (30d)2.02M
Avg Vol (10d)3.96M
Technical Indicators
RSI (14)61.6
MACD0.0867
MACD Signal0.0121
MACD Hist.+0.0746
BB Upper3.567 USD
BB Middle2.951 USD
BB Lower2.336 USD
BB Width41.70%
ATR (14)0.3062 USD
Vol Ratio (20d)1.23x